NAFLD/NASH Medications
The NAFLD/NASH medications' page includes experimental drugs in later phases of development for treatment of non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH).
*generic or biosimilar available
E experimental
DRUG cenicriviroc |
---|
|
GENERIC NAME cenicriviroc |
COMPANY Allergan |
DRUG cilofexor |
---|
|
GENERIC NAME N/A |
COMPANY Gilead Sciences |
DRUG elafibranor |
---|
|
GENERIC NAME elafibranor |
COMPANY Genfit |
DRUG emricasan |
---|
|
GENERIC NAME emricasan |
COMPANY Conatus |
DRUG firsocostat |
---|
|
GENERIC NAME N/A |
COMPANY Gilead Sciences |
DRUG Ocaliva |
---|
|
GENERIC NAME obeticholic acid |
COMPANY Intercept Pharmaceuticals |
DRUG pegbelfermin |
---|
|
GENERIC NAME pegbelfermin |
COMPANY Bristol-Myers Squibb |
DRUG selonsertib |
---|
|
GENERIC NAME selonsertib |
COMPANY Gilead Sciences |
DRUG tropifexor |
---|
|
GENERIC NAME tropifexor |
COMPANY Novartis |